| Bioactivity | KRASG12C IN-12 (compound-1) is a KRASG12C inhibitor. KRASG12C IN-12 (compound-1) can form a ternary complex with intracellular CYPA and the activated KRASG12C mutant[1]. |
| CAS | 2093328-45-9 |
| Formula | C29H39N5O6S2 |
| Molar Mass | 617.78 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Christopher J Schulze, et al. Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS. Science. 2023 Aug 18;381(6659):794-799. |
KRASG12C IN-12
CAS: 2093328-45-9 F: C29H39N5O6S2 W: 617.78
KRASG12C IN-12 (compound-1) is a KRASG12C inhibitor. KRASG12C IN-12 (compound-1) can form a ternary complex with intrace
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.